Table I.
Association between NELFE expressions and clinicopathological features in pancreatic cancer.
| Variable | Total no. of patients n=120 | NELFE expression, n
|
P-value | |
|---|---|---|---|---|
| High | Low | |||
| Age, n (%) | 0.259 | |||
| <60 years | 48 (40.0) | 36 | 12 | |
| ≥60 years | 72 (60.0) | 47 | 25 | |
| Sex, n (%) | 0.646 | |||
| Female | 45 (37.5) | 30 | 15 | |
| Male | 75 (62.5) | 53 | 22 | |
| Chronic pancreatitis, n (%) | 0.546 | |||
| Yes | 57 (47.5) | 44 | 13 | |
| No | 63 (52.5) | 39 | 24 | |
| Tumor size, n (%) | 0.04 | |||
| <2 cm | 42 (35.0) | 34 | 8 | |
| ≥2 cm | 78 (65.0) | 49 | 29 | |
| Differentiation, n (%) | 0.136 | |||
| Well-moderate | 69 (57.5) | 44 | 25 | |
| Poor | 51 (42.5) | 39 | 12 | |
| Lymph-node metastasis, n (%) | 0.001 | |||
| Yes | 69 (57.5) | 39 | 30 | |
| No | 51 (42.5) | 44 | 7 | |
| TNM stage, n (%) | 0.003 | |||
| I-II | 63 (52.5) | 51 | 12 | |
| III-IV | 57 (47.5) | 32 | 25 | |
P<0.05 was considered to indicate a statistically significant result. NELFE, negative elongation factor R; TNM, Tumor-Node-Metastasis.